Multisystem inflammatory syndrome in children related to COVID-19: a systematic review

被引:293
作者
Hoste, Levi [1 ,2 ]
Van Paemel, Ruben [3 ,4 ,5 ]
Haerynck, Filomeen [1 ,2 ]
机构
[1] Ghent Univ Hosp, Dept Pediat Pulmonol Infect Dis & Immunol, Ghent, Belgium
[2] Ghent Univ Hosp, Primary Immunodeficiency Res Lab, Ctr Primary Immunodeficiency Ghent, Jeffrey Modell Diag & Res Ctr, Ghent, Belgium
[3] Ghent Univ Hosp, Ctr Med Genet, Ghent, Belgium
[4] Canc Res Inst Ghent CRIG, Ghent, Belgium
[5] Ghent Univ Hosp, Dept Pediat Hematol Oncol & Stem Cell Transplanta, Ghent, Belgium
关键词
PIMS-TS; MIS-C; COVID-19; SARS-CoV-2; MIMICKING KAWASAKI-DISEASE; SARS-COV-2; PIMS-TS; MIS-C; INVOLVEMENT; SHOCK; INFECTION; DIAGNOSIS;
D O I
10.1007/s00431-021-03993-5
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
An association between a novel pediatric hyperinflammatory condition and SARS-CoV-2 was recently published and termed pediatric inflammatory multisystem syndrome, temporally associated with SARS-CoV-2 (PIMS-TS) or multisystem inflammatory syndrome (in children) (MIS(-C)). We performed a systematic review and describe the epidemiological, clinical, and prognostic characteristics of 953 PIMS-TS/MIS(-C) cases in 68 records. Additionally, we studied the sensitivity of different case definitions that are currently applied. PIMS-TS/MIS(-C) presents at a median age of 8 years. Epidemiological enrichment for males (58.9%) and ethnic minorities (37.0% Black) is present. Apart from obesity (25.3%), comorbidities are rare. PIMS-TS/MIS(-C) is characterized by fever (99.4%), gastrointestinal (85.6%) and cardiocirculatory manifestations (79.3%), and increased inflammatory biomarkers. Nevertheless, 50.3% present respiratory symptoms as well. Over half of patients (56.3%) present with shock. The majority of the patients (73.3%) need intensive care treatment, including extracorporal membrane oxygenation (ECMO) in 3.8%. Despite severe disease, mortality is rather low (1.9%). Of the currently used case definitions, the WHO definition is preferred, as it is more precise, while encompassing most cases. Conclusion: PIMS-TS/MIS(-C) is a severe, heterogeneous disease with epidemiological enrichment for males, adolescents, and racial and ethnic minorities. However, mortality rate is low and short-term outcome favorable. Long-term follow-up of chronic complications and additional clinical research to elucidate the underlying pathogenesis is crucial. What is Known: A novel pediatric inflammatory syndrome with multisystem involvement has been described in association with SARS-CoV-2. To date, the scattered reporting of cases and use of different case definitions provides insufficient insight in the full clinical spectrum, epidemiological and immunological features, and prognosis. What is New: This systematic review illustrates the heterogeneous spectrum of PIMS-TS/MIS(-C) and its epidemiological enrichment for males, adolescents, and racial and ethnic minorities. Despite its severe presentation, overall short-term outcome is good. The WHO MIS definition is preferred, as it is more precise, while encompassing most cases.
引用
收藏
页码:2019 / 2034
页数:16
相关论文
共 102 条
[51]   Distinct clinical and immunological features of SARS-CoV-2-induced multisystem inflammatory syndrome in children [J].
Lee, Pui Y. ;
Day-Lewis, Megan ;
Henderson, Lauren A. ;
Friedman, Kevin G. ;
Lo, Jeffrey ;
Roberts, Jordan E. ;
Lo, Mindy S. ;
Platt, Craig D. ;
Chou, Janet ;
Hoyt, Kacie J. ;
Baker, Annette L. ;
Banzon, Tina M. ;
Chang, Margaret H. ;
Cohen, Ezra ;
de Ferranti, Sarah D. ;
Dionne, Audrey ;
Habiballah, Saddiq ;
Halyabar, Olha ;
Hausmann, Jonathan S. ;
Hazen, Melissa M. ;
Janssen, Erin ;
Meidan, Esra ;
Nelson, Ryan W. ;
Nguyen, Alan A. ;
Sundel, Robert P. ;
Dedeoglu, Fatma ;
Nigrovic, Peter A. ;
Newburger, Jane W. ;
Son, Mary Beth F. .
JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (11) :5942-5950
[52]   COVID-19-Associated Pediatric Multisystem Inflammatory Syndrome [J].
Leon, Maria Paz Deza ;
Redzepi, Ajla ;
McGrath, Eric ;
Abdel-Haq, Nahed ;
Shawaqfeh, Ahmed ;
Sethuraman, Usha ;
Tilford, Bradley ;
Chopra, Teena ;
Arora, Harbir ;
Ang, Jocelyn ;
Asmar, Basim .
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2020, 9 (03) :407-408
[53]   SARS-CoV-2-Induced Kawasaki-Like Hyperinflammatory Syndrome: A Novel COVID Phenotype in Children [J].
Licciardi, Francesco ;
Pruccoli, Giulia ;
Denina, Marco ;
Parodi, Emilia ;
Taglietto, Manuela ;
Rosati, Sergio ;
Montin, Davide .
PEDIATRICS, 2020, 146 (02)
[54]   Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults [J].
Ludvigsson, Jonas F. .
ACTA PAEDIATRICA, 2020, 109 (06) :1088-1095
[55]  
Ma Y., 2022, Biol. Trace Elem. Res, DOI [10.1007/s12011-021-03084, DOI 10.1287/IJOC.2024.0591]
[56]   Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease A Scientific Statement for Health Professionals From the American Heart Association [J].
McCrindle, Brian W. ;
Rowley, Anne H. ;
Newburger, Jane W. ;
Burns, Jane C. ;
Bolger, Anne F. ;
Gewitz, Michael ;
Baker, Annette L. ;
Jackson, Mary Anne ;
Takahashi, Masato ;
Shah, Pinak B. ;
Kobayashi, Tohru ;
Wu, Mei-Hwan ;
Saji, Tsutomu T. ;
Pahl, Elfriede .
CIRCULATION, 2017, 135 (17) :E927-E999
[57]   COVID-19: consider cytokine storm syndromes and immunosuppression [J].
Mehta, Puja ;
McAuley, Daniel F. ;
Brown, Michael ;
Sanchez, Emilie ;
Tattersall, Rachel S. ;
Manson, Jessica J. .
LANCET, 2020, 395 (10229) :1033-1034
[58]   Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages [J].
Merad, Miriam ;
Martin, Jerome C. .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (06) :355-362
[59]   Gastrointestinal Symptoms as a Major Presentation Component of a Novel Multisystem Inflammatory Syndrome in Children That Is Related to Coronavirus Disease 2019: A Single Center Experience of 44 Cases [J].
Miller, Jonathan ;
Cantor, Amanda ;
Zachariah, Philip ;
Ahn, Danielle ;
Martinez, Mercedes ;
Margolis, Kara Gross .
GASTROENTEROLOGY, 2020, 159 (04) :1571-+
[60]  
MORALEDA C, CLIN INFECT DIS, DOI DOI 10.1093/CID/CIAA1042